MNK-1411

Mallinckrodt Starts Phase II Duchenne Muscular Dystrophy Study but Will They Meet Recruitment Targets?
Xtalks
Fri, 08/3/18 - 09:44 am
Mallinckrodt
MNK-1411
Duchenne Muscular Dystrophy
clinical trials